# A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults

> **NCT02778113** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nasal Glucagon
- **DRUG:** Glucagon

## Key facts

- **NCT ID:** NCT02778113
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02778113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02778113, "A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02778113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*